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Nitric oxide exerts a stimulatory role during postnatal ang-
iogenesis. Although soluble guanylyl cyclase (sGC) medi-
ates many of the effects of nitric oxide (NO) in the
vascular system, the contribution of cGMP-dependent vs
cGMP-independent pathways in NO-induced angiogen-
esis remains unclear. Herein, we determined the effects of
a NO donor (sodium nitroprusside; SNP) and a NO-inde-
pendent sGC activator (BAY 41–2272) in the growth and
migration of endothelial cells devoid of sGC. Lack of
enzymatically active sGC in rat aortic EC (RAEC) was
demonstrated through the inability of these cells to accu-
mulate cGMP upon exposure to SNP. However, treatment
of RAEC with SNP promoted a modest increase in their
proliferation and migration that was dependent on extra-
cellular signal regulated kinase1/2 activation. Moreover,
when RAEC were exposed to vascular endothelial growth
factor we observed a 5-fold increase in migration that was
inhibited by NO synthase, but not sGC, inhibition. Infec-
tion of cells with adenoviruses containing sGC greatly
increased the efficacy of SNP as a mitogenic and migratory
stimulus. We conclude that NO is capable of stimulating
EC proliferation and mobility in the absence of sGC; how-
ever, increased intracellular levels of cGMP following sGC
activation greatly amplify the angiogenic potential of NO.
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